RSS

proton-pump inhibitors (PPIs)

According to new research from academia, a drug commonly used to treat gastric issues could potentially be useful in targeting the bacteria that cause tuberculosis (TB). Read more

News

A recently published study has found a link between long-term use of proton pump inhibitors (PPIs) and an increased risk of developing gastric cancer (GC). Read more

News

Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics. Read more

News

A recent study from the University of Eastern Finland has demonstrated that proton pump inhibitors, commonly used as antiulcer drugs in older patients, do not increase the risk of Alzheimer’s disease. Read more

News

A recent study, published in The Lancet, has recommended that patients over the age of 75, receiving aspirin-based antiplatelet treatment, be co-prescribed proton-pump inhibitors (PPIs) to reduce the incidence of upper gastrointestinal bleeding. Read more

News